Search results
Results from the WOW.Com Content Network
The POLST program relies upon teamwork and coordinated systems to ensure preferences are honored throughout the health care system. Research suggests the POLST form accurately represents individual's treatment preferences the majority of the time [17] and that the treatments provided at the end of life match the orders on the form. [18]
Deciding to forego life-sustaining treatment: a report on the ethical, medical, and legal issues in treatment decisions. Washington, DC: President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: For sale by the Supt. of Docs. U.S. G.P.O. Rachels, James. The End of Life: Euthanasia and Morality ...
New York's Family Health Care Decisions Act omits a task force's proposal to allow a physician and ethics review committee to make end-of-life decisions for a patient who lacks capacity and has no surrogate decisionmaker or health care agent, in circumstances where a surrogate could make such decision. [21]
Controversy over these provisions mainly centers on Section 166.046, Subsection (e), 1 which allows a health care facility to discontinue life-sustaining treatment ten days after giving written notice if the continuation of life-sustaining treatment is considered futile care by the treating medical team.
For example, family members may differ over whether life extension or life quality is the main goal of treatment. As it can be challenging for families in the grieving process to make timely decisions that respect the patient's wishes and values, having an established advanced care directive in place can prevent over-treatment, under-treatment ...
The appointed healthcare proxy has, in essence, the same rights to request or refuse treatment that the individual would have if still capable of making and communicating health care decisions. [29] The appointed representative is authorized to make real-time decisions in actual circumstances, as opposed to advance decisions framed in ...
A 2010 survey of more than 10,000 physicians in the United States found respondents divided on the issue of recommending or giving "life-sustaining therapy when [they] judged that it was futile", with 23.6% saying they would do so, 37% saying they would not, and 39.4% selecting "It depends". [3]
The MOLST Program is a New York State initiative that facilitates end-of-life medical decision-making. One goal of the MOLST Program is to ensure that decisions to withhold or withdraw life-sustaining treatment are made in accordance with the patient's wishes, or, if the patient's wishes are not reasonably known and cannot with reasonable diligence be ascertained, in accordance with the ...